A new antiproliferative noscapine analogue: chemical synthesis and biological evaluation

  title={A new antiproliferative noscapine analogue: chemical synthesis and biological evaluation},
  author={Peter E. Ghaly and Rabab M Abou El-Magd and Cassandra D M Churchill and Jack Adam Tuszynski and Frederick G. West},
  pages={40518 - 40530}
Noscapine, a naturally occurring opium alkaloid, is a widely used antitussive medication. Noscapine has low toxicity and recently it was also found to possess cytotoxic activity which led to the development of many noscapine analogues. In this paper we report on the synthesis and testing of a novel noscapine analogue. Cytotoxicity was assessed by MTT colorimetric assay using SKBR-3 and paclitaxel-resistant SKBR-3 breast cancer cell lines using different concentrations for both noscapine and the… 

Figures and Tables from this paper

Discovery of noscapine derivatives as potential β-tubulin inhibitors.
Synthesis and biological evaluation of structurally simplified noscapine analogues as microtubule binding agents
The results indicate that these compounds have relatively low cytotoxicity profile and less pronounced effects on microtubule dynamicity assessments.
Synthesis and Pharmacological Evaluation of Noscapine-Inspired 5-Substituted Tetrahydroisoquinolines as Cytotoxic Agents.
Insight is provided into structural modifications to noscapine that will guide future development toward more potent cytotoxic agents that are active against resistant cancer cells and, in combination studies, potentiate the antiproliferative activity of vinblastine.
Imidazo[2,1-b]thiazole-Coupled Natural Noscapine Derivatives as Anticancer Agents
The results indicated that these noscapine analogues may serve as novel compounds that can possibly inhibit tubulin protein and can be considered for further optimization as a clinical candidate for treating pancreatic cancer.
1,3‐Benzodioxole‐Modified Noscapine Analogues: Synthesis, Antiproliferative Activity, and Tubulin‐Bound Structure
The design, synthesis and pharmacological evaluation of noscapine analogues consisting of modifications to the 1,3-benzodioxole moiety, including expansion of the dioxolane ring and inclusion of metabolically robust deuterium and fluorine atoms are described.
Semi-Synthesis of New 1,2,3-Triazole Derivatives of 9-Bromonoscapine and their Anticancer Activities
Among the synthesized compounds, those with a hydroxylated aliphatic side chain (5p, 5q, and 5r) showed the highest activities and had the highest docking scores and effective interactions with binding sites equal to -8.074, -7.425 and - 7.820 kcal/mol, respectively.
Anti-proliferative activity of epigallocatechin-3-gallate and silibinin on soft tissue sarcoma cells
The green tea polyphenol EGCG and the natural flavonoid silibinin from milk thistle suppressed the proliferation and viability of liposarcoma, synovial sarcoma and fibrosarcomas cells.
A review of research progress of antitumor drugs based on tubulin targets
A basic overview of tubulin and the main mechanism of anti-tumor drugs is introduced and the application of drugs which developed based on the three domains of Tubulin to various cancers in various fields are focused on.


Development of a Novel Nitro-Derivative of Noscapine for the Potential Treatment of Drug-Resistant Ovarian Cancer and T-Cell Lymphoma
9-nitro-nos has great potential to be a novel therapeutic agent for ovarian and T-cell lymphoma cancers, even those that have become drug-resistant to currently available chemotherapeutic drugs.
Second generation benzofuranone ring substituted noscapine analogs: synthesis and biological evaluation.
Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent
A simple, sensitive, quantitative, selective, and less time-consuming high-performance liquid chromatography (HPLC) method for determination of noscapine and to study its pharmacokinetics in mice models is developed.
Rational Design of Novel Anti-microtubule Agent (9-Azido-Noscapine) from Quantitative Structure Activity Relationship (QSAR) Evaluation of Noscapinoids
To obtain systematic insight into the relationship between the structural framework of noscapine scaffold and its antitumor activity, the authors synthesized strategic derivatives (including two new ones in this article) that turned out to be very close to predicted pIC50.
Synthesis and biological evaluation of a cyclic ether fluorinated noscapine analog.
Rational Design, Synthesis, and Biological Evaluation of Third Generation α-Noscapine Analogues as Potent Tubulin Binding Anti-Cancer Agents
The study reported here identified potent, third generation noscapinoids as new anti-cancer agents that perturbed DNA synthesis, delayed the cell cycle progression at G2/M phase, and induced apoptotic cell death in cancer cells.
Synthesis and in vitro cytotoxicity of haloderivatives of noscapine.
Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses
Oral noscapine has the potential to be an effective chemotherapeutic agent for the treatment of human cancer and showed little or no toxicity to kidney, liver, heart, bone marrow, spleen or small intestine at tumor-suppressive doses.
The anti-cancer activity of noscapine: a review.
Noscapine is an isoqiunoline alkaloid found in opium latex that has great potential as novel anti-cancer agents and has been introduced as an anti-mitotic agent.
Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation.
Two brominated derivatives of noscapine, 5- Br-nosc and reduced 5-bromonoscapine (Rd 5-Br- nosc) have higher tubulin binding activity than nos capine and affect tubulin polymerization differently from noscapINE, and are able to arrest cell cycle progression at mitosis at concentrations much lower than Noscapine.